79.27
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $79.27, with a volume of 10.02M.
It is down -0.09% in the last 24 hours and up +0.85% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$79.34
Open:
$79.165
24h Volume:
10.02M
Relative Volume:
1.01
Market Cap:
$101.47B
Revenue:
$36.36B
Net Income/Loss:
$4.84B
P/E Ratio:
21.30
EPS:
3.7212
Net Cash Flow:
$5.43B
1W Performance:
-1.38%
1M Performance:
+0.85%
6M Performance:
-18.87%
1Y Performance:
-8.19%
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
79.27 | 101.56B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
ABT
Abbott Laboratories
|
87.83 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
304.69 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
44.33 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.88 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Resumed | Barclays | Overweight |
| Feb-09-26 | Upgrade | Needham | Hold → Buy |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Jan-30-26 | Resumed | Wells Fargo | Overweight |
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
This Undervalued Medical-Devices Stock Is Poised for a Rebound - Barron's
Is It Worth Investing in Medtronic (MDT) Based on Wall Street's Bullish Views? - Yahoo Finance
Medtronic (MDT) Completes $550M Acquisition of Scientia Vascular - Yahoo Finance
Medtronic (MDT) Stock Could Be 12.2% Undervalued After Strong Revenue Growth - simplywall.st
Healthcare Services Market Size to Worth USD 20.10 Trillion by 2035, Amid Rising Digital Healthcare Adoption – SNS Insider - GlobeNewswire Inc.
United States Pacemakers Market to Reach US$ 6.99 Billion by 2033 - openPR.com
Medtronic Introduces PulseSelect™ PFA Technology to address India’s Growing AFib and Stroke Burden - Passionate In Marketing
Medtronic completes acquisition of Scientia Vascular - Today's Medical Developments
Medtronic plc 2026 10-K Report: Financial Performance, Business Segments, and Global Operations Overview - Minichart
MDT News | MEDTRONIC PLC (NYSE:MDT) - ChartMill
American Society of Anesthesiologists Announces 12-Year Collaboration with Medtronic as a Corporate Supporter | Newswise - Newswise
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Medtronic plc FY 2026: Revenue $36.36B, EPS $3.73— 10-K Summary - TradingView
[IRANNOTICE] Medtronic plc SEC Filing - Stock Titan
Diabetes spin-off, AI and regulation reshape Medtronic (MDT) medical device strategy - Stock Titan
Medtronic StockAnalyst views diverge as tariff overhang meets robust pipeline - AD HOC NEWS
Medtronic (MDT) Stock Down 26%: Wall Street Sees 50%+ Upside Potential - parameter.io
Medtronic (MDT) Stock Down 26%: Why Wall Street Is Calling It a Strong Buy - Blockonomi
Medtronic (MDT) Stock Down 26%: Why Wall Street Sees 50% Upside Ahead - MoneyCheck
Medtronic (MDT) Stock Is Down 26% From Its High — Analysts Say Buy It Now - CoinCentral
Medtronic (MDT): Company Profile, Stock Price, News, Rankings - Fortune
A Look at Medtronic PLC (MDT) After 3.9% Decline -- GF Value $99 - GuruFocus
Medtronic PLC (MDT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Medtronic PLC stock underperforms Wednesday when compared to competitors - MarketWatch
Medtronic PLC (MDT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Is the Options Market Predicting a Spike in Medtronic Stock? - Yahoo Finance
Truist Maintains Hold on Medtronic (MDT), Seeks Stronger EPS Growth - Insider Monkey
Medtronic closes Scientia Vascular takeover, continuing M&A streak - MedTech Dive
Medtronic acquires neurovascular access device maker Scientia Vascular for $550M - Medical Economics
Medtronic PLC $MDT Stock Position Increased by USS Investment Management Ltd - MarketBeat
Medtronic PLC $MDT Shares Acquired by Panagora Asset Management Inc. - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Purchases 258,783 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Eventide Asset Management LLC - MarketBeat
Barclays PLC Has $215.27 Million Stock Holdings in Medtronic PLC $MDT - MarketBeat
Arax Advisory Partners Has $2.63 Million Position in Medtronic PLC $MDT - MarketBeat
Should I Buy MDT (Medtronic plc) | AI Analysis, Technical & News Insights - Kavout
BofA Lowers PT on Medtronic (MDT) Stock - Insider Monkey
Epoch Investment Partners Inc. Sells 49,576 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT is Avidity Partners Management LP’s 7th Largest Position - InsuranceNewsNet
Medtronic PLC $MDT is Avidity Partners Management LP's 7th Largest Position - MarketBeat
Arrowstreet Capital Limited Partnership Increases Stock Position in Medtronic PLC $MDT - MarketBeat
Analyst Lowers Medtronic (MDT) Price Target by $15. Here is Why - Yahoo Finance
Medtronic plc Stock (IE00BTN1Y115): Valuation metrics in focus for US investors - AD HOC NEWS
Y Intercept Hong Kong Ltd Buys 132,074 Shares of Medtronic PLC $MDT - MarketBeat
Vontobel Holding Ltd. Buys 520,768 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
State Street Corp Buys 1,199,621 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Korea Investment CORP - MarketBeat
Medtronic PLC $MDT is Rhenman & Partners Asset Management AB's 4th Largest Position - MarketBeat
Medtronic PLC $MDT Shares Bought by Macquarie Group Ltd. - MarketBeat
First National Bank of Omaha Has $8.02 Million Position in Medtronic PLC $MDT - MarketBeat
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):